Home/Pipeline/SJP-001

SJP-001

Hangover Prevention

Phase 2Active (Collaboration with Sen-Jam Pharmaceutical)

Key Facts

Indication
Hangover Prevention
Phase
Phase 2
Status
Active (Collaboration with Sen-Jam Pharmaceutical)
Companies

About Cliantha Research

Cliantha Research is a leading Indian CRO with a 21-year history of excellence, operating under the motto 'Science with Integrity.' The company offers end-to-end clinical trial services, including early and late-phase studies, biometrics, and specialized research in areas like respiratory and dermatology. It maintains a strong regulatory compliance record with agencies like the USFDA, WHO, MHRA, and Health Canada, and has expanded its capabilities with advanced infrastructure like environmental exposure chambers and LCMS/MS systems.

View full company profile

About Sen-Jam Pharmaceutical

Sen-Jam Pharmaceutical is an early-stage biotech pioneering a novel approach to immuno-regulation with its PAIR platform, which combines two repurposed molecules to modulate inflammation upstream. The company has a broad pipeline spanning from preclinical to Phase 2, targeting multi-trillion-dollar health burdens including obesity/MASH, opioid use disorder, respiratory infections, and critical care inflammation. By aiming to shift treatment paradigms from reactive symptom management to proactive immune modulation, Sen-Jam seeks to extend healthspan and reduce the global economic burden of chronic disease.

View full company profile